Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Markowitz

Showing results (601-610 of 604) with videos related to

Pageof 61
Sort By:
You have reached the last page of results.This site can display upto 604 results.
Medrxiv : the Preprint Server for Health Sciences|September 26, 2025
Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter StudyOlives Nguyen, Jack Wiedrick, Daniele Massera, et al.
Journal of Cardiac Failure|March 3, 2026
Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter StudyOlives Nguyen, Jack Wiedrick, Daniele Massera, et al.
Mayo Clinic Proceedings|October 7, 2023
Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel ClassificationSanjeev Sethi, Laurence H Beck, Richard J Glassock, et al.
Kidney International|October 5, 2023
Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classificationSanjeev Sethi, Laurence H Beck, Richard J Glassock, et al.
Pageof 61

Showing results (601-610 of 604) with videos related to

Sort By:
Pageof 61
You have reached the last page of results.This site can display upto 604 results.
Medrxiv : the Preprint Server for Health Sciences|September 26, 2025
Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter StudyOlives Nguyen, Jack Wiedrick, Daniele Massera, et al.
Journal of Cardiac Failure|March 3, 2026
Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter StudyOlives Nguyen, Jack Wiedrick, Daniele Massera, et al.
Mayo Clinic Proceedings|October 7, 2023
Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel ClassificationSanjeev Sethi, Laurence H Beck, Richard J Glassock, et al.
Kidney International|October 5, 2023
Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classificationSanjeev Sethi, Laurence H Beck, Richard J Glassock, et al.
Pageof 61